دورية أكاديمية
Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis
العنوان: | Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis |
---|---|
المؤلفون: | Jauslin, Petra, Kulkarni, Pooja, Li, Hanbin, Vatakuti, Suresh, Hussain, Azher, Wenning, LarissaAff2, Aff3, Kerbusch, Thomas |
المصدر: | Clinical Pharmacokinetics. 58(8):1059-1068 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 03125963 11791926 |
---|---|
DOI: | 10.1007/s40262-019-00743-7 |